![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Everlab_0B1A1234.jpg\")
Everlab co-founder and chief medical officer Dr Steven Lu. | Images: Supplied<\/p>\n\t\t\t\t\t\t\tPublished on\t\t\t\t\t\t<\/p>\n
\t\t\t\t\t\t\tJuly 22, 2025\n\t\t\t\t\t<\/p>\n
Melbourne startup Everlab is blending AI, full-body diagnostics and deep data to transform preventive medicine \u2014 and it all began with a non-routine trip to the doctor.<\/p>\n
Everlab co-founder and chief medical officer Dr Steven Lu. | Images: Supplied<\/p>\n
Key Takeaways<\/p>\n
Everlab has raised $15 million in a seed round led by global growth equity firm Left Lane Capital to accelerate its international expansion and platform development.<\/p>\n
Targeting the global burden of chronic disease, Everlab was founded on the idea of getting hold of ostensibly well people before symptoms appeared.<\/p>\n
The Melbourne-based startup uses proprietary AI agents to analyse complex health data, automate clinical summaries, and recommend personalised interventions.<\/p>\n
Everlab claims tens of thousands on its waitlist, with expectations of 20x growth this year.<\/p>\n
It has analysed over 1 million biomarkers in its customers, finding one quarter to be abnormal.<\/p>\n
Left Lane Capital called Everlab a \u201ccategory-defining platform\u201d.<\/p>\n
It all started when Sam Kothari \u2013 employee number three in Airwallex\u2019s commercial team \u2013 came in for a checkup with Dr Steven Lu at his Melbourne clinic. \u00a0<\/p>\n
Kothari\u2019s father had suffered a heart attack at age 48 and his best friend\u2019s dad had just died of cancer at 52. Kothari and his friend started to obsess about not following them on that increasingly common path. Eight in ten Australians suffer from a serious long-term health condition while half suffer a chronic illness<\/a>, most of which come with some other comorbidity. \u00a0<\/p>\n Diabetes affects 1.3 million.<\/p>\n \u201cWe were both anxious about what lay ahead and we started reading books, listening to podcasts, trying to find doctors who could give us some assurance about the path we were on,\u201d Kothari tells Forbes Australia.<\/p>\n Dr Lu was recommended to them. Lu had started his medical career in intensive care and loved the act of saving lives, but was disheartened by seeing many of his patients have their lives ruined by the complications of chronic disease.<\/p>\n \u201cSeen through an intensive-care lens, they\u2019re a success, but through a life lens you can\u2019t say that,\u201d Lu tells Forbes Australia. \u201cIf they survive 90 days after discharge, that\u2019s a win on our stats, but then they leave, they can\u2019t have a relationship, they can\u2019t hold down a job, they\u2019ve got memory problems, PTSD from their treatment, and they\u2019ve already got plaque in their arteries, they\u2019re already diabetic, and on insulin.<\/p>\n \u201cI\u2019m not a better GP than others. I\u2019ve just got a different incentive structure.\u201d<\/p>\n Dr Steven Lu<\/p>\n \u201cIt fueled my passion. Intensive care is important, but we have to solve the cause. Why do people end up in intensive care with any chronic disease? Everyone talks about prevention being the best cure, that it\u2019s the most economical way to treat diseases, but we don\u2019t invest in it. Medical students don\u2019t get trained in it.\u201d<\/p>\n Lu moved into general practice but realised it was just a slightly earlier point on the same sickcare treadmill crammed into 15-minute consults.<\/p>\n And so he started his own practice with the hope of getting people before they became sick. People like Kothari.<\/p>\n Health 0.0<\/p>\n Kothari was a 30-year-old who thought nothing of pulling 16-hour days in startup land. He didn\u2019t have any symptoms so, understandably, was always being told by doctors that he should work on his sleep, exercise a bit more, but he was fine. He wanted to go deeper.<\/p>\n The first thing Kothari noticed was that Lu ran his own website, used Calendly to book, and that he was then onboarded digitally before he\u2019d arrived. \u201cSeeing his online efforts and his adoption of technology we had a hunch this might be worth it,\u201d says Kothari. \u201cIt wasn\u2019t cheap, but I felt it would be worth the 390 bucks.\u201d<\/p>\n In the first five minutes, Kothari kept looking at his watch, he was so used to being rushed in clinical settings. \u201cSteven had to tell me: \u2018Take off your watch. Pay attention. We\u2019re here to talk about you.\u2019\u201d<\/p>\n Forty-five minutes later, when he left, there was no one at the front desk. \u201cIt felt like that first time you used an Uber and didn\u2019t know if you had to pay the driver. It was such a different experience: being asked questions I\u2019d never been asked before; having this seamless operation \u2026 It was transformational, and I\u2019m not even talking about all the issues he found and what we covered. \u00a0<\/p>\n \u201cAs consumers, when we find a doctor who listens, who cares, we latch onto them. That was the journey with Steven, trying to figure out: \u2018What\u2019s my risk of a heart attack? What\u2019s my risk of diabetes?<\/p>\n \u201cSteven\u2019s program was version zero of what Everlab became, he was experimenting with that real deep onboarding. Understanding your family history. Building out your goals. Then the investigation. I did a DEXA scan [for bone density, muscle and fat mass]. Did full blood tests, my strength measured by a physio. It turned out I had osteopenia, brittle bones. Very unusual for a male in their 30s. I had worse bone density than my mum who was post-menopausal. I was a higher risk of heart disease, especially when you looked at some of the more advanced cardiovascular risk biomarkers like lipoprotein A, apolipoprotein B, and my blood sugars were also elevated so I was on the border of prediabetic.\u201d<\/p>\n Lu drew Kothari a graph of his heart-disease risk and he was three times higher than the average person. \u201cHearing that in your 30s is pretty confronting.\u201d<\/p>\n But the knowledge of how to fix it was also empowering \u2013 from an exercise program to being told next time he was at the supermarket to buy X brand instead of Y.<\/p>\n \u201cMy bone health started to improve, my cholesterol markers came down. I\u2019m no longer on the verge of prediabetic.\u201d<\/p>\n Kothari became a convert and started proselytising his family and friends.<\/p>\n \u201cI told my parents, \u2018You have to see this guy. I\u2019ll pay. I think he\u2019s going to change your life.\u2019 Steven\u2019s so humble, he always says, \u2018I\u2019m not a better GP than others. I\u2019ve just got a different incentive structure.\u2019 But I think he\u2019s an exceptional GP.\u201d<\/p>\n \u201cWe have very global ambitions for the product and the experience.\u201d <\/p>\n Everlab co-founder Sam Kothari<\/p>\n In mid-2023, about six months after starting with Lu, Kothari asked him if he had larger ambitions for the practice. Lu did. Lu wanted to change the way medicine was practiced across the board. \u00a0<\/p>\n \u201cWe realised we couldn\u2019t scale it with just the two of us. He\u2019s a clinician. I focus on operations. We had important skill gaps. We knew how important it was to have a really strong technical software lens to this problem. We also didn\u2019t understand growth, brand, design.\u201d<\/p>\n They brought in Anshul Jain for the tech side and Marc Hermann, co-founder of German supplements brand Foodspring. Hermann and Jain also had similar family histories. \u201cIt was kind of this beautiful mission alignment, for all of us,\u201d says Kothari.<\/p>\n \u201cWe started Everlab to build the infrastructure for fully automated preventative health care. We want to build the infrastructure including physical labs and diagnostic hubs, including software, to collect and interpret patient data, to provide automated, seamless diagnosis and preventative care treatment options.<\/p>\n \u201cWe\u2019re essentially a health record. We\u2019re consolidating medical data, lifestyle data, imaging, pathology, all of that data into a central point to then allow our members and patients to access preventative diagnostics, doctor consults, dieticians, lifestyle advice \u2013 a host of value to enable them to reduce their risk of chronic disease.\u201d<\/p>\n He cites the two-week diet diaries, the blood markers not covered by Medicare, the extra scans, VO2 max testing and continuous glucose monitors as examples of where Everlab goes further than a standard consult. <\/p>\n \u201cWe can pull 20 years of pathology data. The GP doesn\u2019t need to request that. Our system does that automatically, once we have patient consent.<\/p>\n \u201cSo our GPs get to see a nice graph of the patient\u2019s pathology markers. They can see the trend and how it\u2019s shifting and changing. They don\u2019t have to sift through 20 years of PDF fax reports, calibrating numbers and trying to figure out is it going up or down or left or right.\u201d<\/p>\n Lu sees Everlab tackling the current chronic health crisis as having one central cause that manifests as multiple different illnesses.<\/p>\n \u201cIf you think about cardiovascular disease, it\u2019s still the biggest killer of men and women in the west. But the rate of cancer between the ages of 15 and 39 has gone up 40% since the 1980s. Neuro-degenerative diseases are rising. We have to pause and ask, \u2018Why?\u2019\u201d<\/p>\n Lu saw that one illness often went with the other: that his cancer patients were often dying of heart attacks; that they often went hand in glove with mental illness. And he began coming round to the notion that they\u2019re all part of the same problem.<\/p>\n \u201cMetabolic health is the central hub of all these chronic conditions. It\u2019s critically important. It\u2019s not just about, \u2018Are you fat and do you have diabetes?\u2019 We have to look much closer at metabolic processes. We\u2019re more sedentary, eating more processed foods, all of which are bad for your metabolic health and there\u2019s a very, very strong link between poor metabolic health and your mental health.<\/p>\n \u201cMetabolic health is closely tied to your digestive health and your microbiome and the brain\/gut axis. One of the biggest things in the next five, ten years, will be understanding the link between them.\u201d<\/p>\n The two most important metrics for Lu are the blood sugar readings from the continuous glucose monitor, and the body composition as revealed by the DEXA scan. \u201cI don\u2019t care about BMI. I care about what your fat mass index is. I care about your visceral fat. I care about whether you have fat inside your liver and about your musculature, because having good muscle mass is critical for good metabolic performance.\u201d<\/p>\n AI analyses the results but a doctor still needs to sign off. \u201cBut the time it takes me goes from 30 minutes to 3 or 4 minutes,\u201d says Lu. \u201cThat\u2019s what we can do today, but the power of that will get higher and higher as AI and large language models change the landscape of even research.\u201d<\/p>\n What price health?<\/p>\n Everlab\u2019s main membership costs $3,000 for 12 months, including six-monthly full suite of tests and a digital dashboard showing the results. Diagnostic membership is $1,500, including medical insights, but not lifestyle and performance-based assessment, VO2 max, physical tests, CGM and diet tracking<\/p>\n Everlab raised $3 million in a pre-seed round in December 2023, led by b2venture, a European fund that had backed Hermann\u2019s previous company.<\/p>\n \u201cWe believe everyone deserves access to world-class preventive care,\u201d said Everlab CEO Hermann said after the $15 million seed round was announced. \u201cBy combining AI with the knowledge of leading clinicians, we\u2019ve built a new kind of health platform designed to deliver smarter, earlier care to millions.\u201d<\/p>\n Everlab claims it has tens of thousands of customers on its waitlist with \u201cgrowing demand across both consumer and enterprise markets, the company is on track for 20x growth this year\u201d.<\/p>\n \u201cTo date, Everlab has processed over 1,000,000 biomarkers through full-body health<\/p>\n Testing,\u201d the company said in a press release. \u201cAlarmingly, one in four test results are abnormal, and for 2.5% of members, findings have been life-changing \u2014 uncovering serious conditions such as blocked arteries, gastrointestinal tumours, early-stage cancers, and congenital brain abnormalities.\u201d<\/p>\n Laura Sillman, principal at Left Lane Capital, said preventive care had always been a medical ideal but rarely a commercial reality. \u201cEverlab has built a product and model that makes it scalable, combining clinical depth with software leverage and operational precision. We\u2019re excited to support them as they build a category-defining platform.\u201d<\/p>\n Everlab says it will use the $15 million to grow its clinic network, expand its engineering and clinical teams, and advance its AI-powered infrastructure \u2014 laying the foundation for a global, scalable system of preventive healthcare.<\/p>\n As for Kothari, he sees Australia as the perfect place to launch from, but he\u2019s keen to tackle Asia\u2019s looming metabolic crisis. \u201cWe\u2019re all running into this \u2013 these lifestyle and non-communicable diseases. I have a huge passion for Asia, especially given my Indian heritage. The prevalence of diabetes in India is quite concerning and accelerating. I spent a whole bunch of time in Asia with Airwallex<\/a>. And I think there\u2019s a huge opportunity there to help them understand how to shift as a society.<\/p>\n \u201cSo yeah, we have very global ambitions for the product and the experience. Starting in Australia makes a lot of sense \u2013 being highly regulated forces you to build a product that\u2019s clinically sound and safe for patients. Our healthcare system is very well respected and that allows us then to build something that\u2019s quite robust and take it into the U.S., the U.K., Asia, and really deploy the smarts behind what we\u2019re doing.\u201d<\/p>\n Look back on the week that was with hand-picked articles from Australia and around the world.\u00a0Sign up to the Forbes Australia newsletter here<\/a>\u00a0or\u00a0become a member here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Published on July 22, 2025 Melbourne startup Everlab is blending AI, full-body diagnostics and deep data to transform…\n","protected":false},"author":2,"featured_media":13162,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[14877,14878,64,63,14879,14575,137,500,14880,14881,9153,14882],"class_list":["post-13161","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-airwallex","tag-anshul-jain","tag-au","tag-australia","tag-dr-steven-lu","tag-everlab","tag-health","tag-healthcare","tag-left-lane-capital","tag-marc-hermann","tag-metabolic-health","tag-sam-kothari"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/13161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=13161"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/13161\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/13162"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=13161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=13161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=13161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Everlab_Founding-team_Sam.jpg\")
Everlab co-founder Sam Kothari. | Image: Supplied<\/p>\n![\"Everlab](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Steven_Skin_Check.jpg\")
Everlab co-founder Dr Steven Lu at work.<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/ECG.jpg\")
<\/p>\n![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Team_Everlab_Sit_Horizontal_NEW-1.png\")
Everlab founders, from left, Marc Hermann, Anshul Jain, Steven Lu and Sam Kothari. <\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/VO2_2.jpg\")
VO2 max testing evaluates the body\u2019s ability to use oxygen.<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Clinic_Entrance.jpg\")
<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/07\/Overlay_app.jpg\")
The Everlab dashboard.<\/p>\n